全文获取类型
收费全文 | 1081481篇 |
免费 | 74264篇 |
国内免费 | 1670篇 |
专业分类
耳鼻咽喉 | 15109篇 |
儿科学 | 34753篇 |
妇产科学 | 28703篇 |
基础医学 | 154390篇 |
口腔科学 | 29745篇 |
临床医学 | 95969篇 |
内科学 | 204911篇 |
皮肤病学 | 24565篇 |
神经病学 | 81887篇 |
特种医学 | 43322篇 |
外国民族医学 | 203篇 |
外科学 | 163998篇 |
综合类 | 22751篇 |
现状与发展 | 3篇 |
一般理论 | 267篇 |
预防医学 | 75166篇 |
眼科学 | 24665篇 |
药学 | 87175篇 |
15篇 | |
中国医学 | 3266篇 |
肿瘤学 | 66552篇 |
出版年
2021年 | 8065篇 |
2019年 | 8116篇 |
2018年 | 11663篇 |
2017年 | 9246篇 |
2016年 | 10406篇 |
2015年 | 11671篇 |
2014年 | 15798篇 |
2013年 | 22799篇 |
2012年 | 31358篇 |
2011年 | 33018篇 |
2010年 | 19474篇 |
2009年 | 18209篇 |
2008年 | 30435篇 |
2007年 | 32557篇 |
2006年 | 33115篇 |
2005年 | 31412篇 |
2004年 | 30067篇 |
2003年 | 28892篇 |
2002年 | 27799篇 |
2001年 | 60201篇 |
2000年 | 61631篇 |
1999年 | 51034篇 |
1998年 | 12508篇 |
1997年 | 11048篇 |
1996年 | 11055篇 |
1995年 | 10366篇 |
1994年 | 9375篇 |
1993年 | 8877篇 |
1992年 | 37831篇 |
1991年 | 36329篇 |
1990年 | 35780篇 |
1989年 | 34316篇 |
1988年 | 30886篇 |
1987年 | 30019篇 |
1986年 | 28231篇 |
1985年 | 26466篇 |
1984年 | 19198篇 |
1983年 | 16122篇 |
1982年 | 8831篇 |
1979年 | 17046篇 |
1978年 | 11413篇 |
1977年 | 10235篇 |
1976年 | 8844篇 |
1975年 | 10075篇 |
1974年 | 11663篇 |
1973年 | 11288篇 |
1972年 | 10760篇 |
1971年 | 10098篇 |
1970年 | 9257篇 |
1969年 | 8947篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Hassen Lena M. Albarrak Rana A. Albahlal Reem A. Alsaqabi Dimah K. Hassen Ikhlass M. Daghestani Maha H. Alqurtas Eman M. Alkhalaf Abdulaziz T. Bedaiwi Mohammed K. Omair Mohammed A. Almaghlouth Ibrahim A. 《Quality of life research》2022,31(11):3229-3239
Quality of Life Research - The COVID-19 pandemic might add to the stressors experienced by people living with rheumatic diseases. This study aimed to examine rheumatic patients’ functional... 相似文献
3.
Molnár B. Aroca S. Dobos A. Orbán K. Szabó J. Windisch P. Stähli A. Sculean A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with... 相似文献
4.
5.
6.
7.
8.
Background:We aim to evaluate the efficiency of Raman spectroscopy (RS) in diagnosing suspected patients with intrahepatic cholangiocarcinoma (ICC), manifested by diagnostic sensitivity, specificity, and accuracy.Methods:We will research widely the articles concerning the use of RS in ICC through authenticated database including PubMed/Medline, EMBASE, Web of Science, Ovid, Web of Knowledge, Cochrane Library, and CNKI between January 2012 and November 2020, retrieving at least 1500 spectra with strict criteria. This study will be carried out in accordance to Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. We are going to summarize the test performance using random effects models.Results:Based on the pooled sensitivity, specificity, and diagnostic accuracy, we intend to provide the relative diagnostic efficiency in ICC through RS.Conclusion:Through this systematic review and meta-analysis, we intend to provide the pooled sensitivity, specificity and diagnostic accuracy of RS in the diagnosis of suspected ICC. Other parameters like positive likelihood ratios (LR), negative LR, diagnostic odds ratio (DOR), and area under curve (AUC) of the summary receiver operating characteristics (SROC) curve will also be calculated and related figures will be drawn to help illustrate the efficacy of RS in the diagnosis of ICC. 相似文献
9.
10.
Jesus K Yamamoto-Furusho Norma N Parra-Holgu n 《World journal of gastroenterology : WJG》2021,27(48):8242-8261
Inflammatory bowel disease (IBD) is a chronic disease that requires chronic treatment throughout the evolution of the disease, with a complex physiopathology that entails great challenges for the development of new and specific treatments for ulcerative colitis and Crohn´s disease. The anti-tumor necrosis factor alpha therapy has impacted the clinical course of IBD in those patients who do not respond to conventional treatment, so there is a need to develop new therapies and markers of treatment response. Various pathways involved in the development of the disease are known and the new therapies have focused on blocking the inflammatory process at the gastrointestinal level by oral, intravenous, subcutaneous, and topical route. All these new therapies can lead to more personalized treatments with higher success rates and fewer relapses. These treatments have not only focused on clinical remission, but also on achieving macroscopic changes at the endoscopic level and microscopic changes by achieving mucosal healing. These treatments are mainly based on modifying signaling pathways, by blocking receptors or ligands, reducing cell migration and maintaining the integrity of the epithelial barrier. Therefore, this review presents the efficacy and safety of the new treatments that are currently under study and the advances that have been made in this area in recent years. 相似文献